ular myocytes. This process is complete by 10.5 d p.c. During this time, MHCa mRNA levels decrease in ventricular muscle cells but continue to be expressed at high levels in atrial muscle cells. MHCot transcripts continue to decrease in ventricular myocytes until 16 d p.c., when they are detectable at low levels, but then increase, and finally replace MHC/3 mRNAs in ventricular muscle by 7 d after birth. Like MHC/~, MLC1V transcripts become restricted to ventricular myocytes, but at a slower rate. MLCIV mRNAs continuc to be detected at low levels in atrial cells until 15.5 d p.c. MLC1A mRNA levels gradually decrease but are still detectable in ventricular cells until a few days after birth. This dynamic pattern of changes in the myosin phenotypc in the prenatal mouse heart suggests that there are different regulatory mechanisms for cell-specific expression of myosin isoforms during cardiac development.
C
ARDIAC muscle is known to contain at least two different isoforms of myosin heavy chain (MHC) t and two myosin alkali light chains (MLC), which are encoded by distinct genes (Mahdavi et al., 1982; Barton et al., , 1988 . The genes encoding the two MHC proteins, called MHCa and MHCB (Hob et al., 1978) , are organized in tandem and are developmentally and hormonally regulated (Lomprd et al., 1984) . These genes are also regulated differentially in response to cardiac hypertrophy due to hemodynamic overload (Izumo et al., 1987; reviewed in Nadal-Ginard and Mahdavi, 1989) . The MLC genes, MLCIA and MLCIV, are coexpressed and developmentally regulated in cardiac and skeletal muscle Lyons ct al., 1990b) . These MLC genes are regulated differentially during cardiac hypertrophy in humans (Cummins, 1982; Kurabayashi et al., 1988) but not in rodents (Rovner et al., 1990) , and do not appear to be hormonally regulated (Schwartz et al., 1982) . In the adult rodent heart, MLC1V is present in the ventricles and MLCIA in the atria, while MHCct is the major isoform in both compartments.
Most of the reports on myosin expression in embryonic cardiac muscle have involved antibody studies of the chick heart. Zhang et al. (1986) and Sweeney et al. (1987) report that at Hamburger-Hamilton stage 10 (1.25 d in ovo), only the adult ventricular MHC is detectable. Approximately 1 d later, stage 12-15, atrial MHC starts to be expressed in embryonic chick hearts. There is one report of an antibody study of MHCs in the embryonic rat heart. De Groot et al. (1989) show that MHCo~ and MHC/~ are coexpressed in tubular rat hearts (embryonic day 10-11). Biochemical studies of developing mammalian hearts have shown that MHC/3 is the predominant MHC in late fetal ventricles (Lompr6 et al., 1981; Schwartz et al., 1982) . However, there are variations in the developmental patterns of MHC protein expression in the ventricles of different mammalian species (Lompr6 et al., 1981) . Variations in MHC proteins in atria and ventricles appear to be related to animal size (Syrovy, 1985) . There are a few studies of the MLC protein content of fetal cardiac muscle; these have shown that MLC1A is expressed in fetal ventricles (Whalen and Sell, 1980; Cummins and Lambert, 1986) .
We are interested in the regulation of myosin gene expression in the developing manunalian heart, particularly at early stages in the embryo. To characterize the normal pattern of expression of MHC and MLC genes, we have used isoform-specific cRNA probes to MHCc~, MHC~, MLC1A, and MLC1V mRNAs for in situ hybridization of the mouse embryonic and fetal heart. We show that, after an initial high level of coexpression in the myocardium of the cardiac tube at 8 d post coitum (p.c.), each of these transcript s has a different pattern of accumulation suggesting that each is regulated in a different cell-specific and stage-specific manner in developing atrial and ventricular myocytes.
Materials and Methods

Preparation and Prehybridization of Tissue Sections
The protocol that was used to fix and embed C3H and BALB/c mouse embryos, fetuses, and postnatal hearts is described in detail in Sassoon et al. (1988) . Ages and numbers of embryos and fetuses examined are listed in Table I . Briefly, embryos were fixed in 4% paraformaldehyde in PBS, dehydrated, and intiltrated with paraffin. 5-7-/~m-thick serial sections were mounted on subbed slides (Gall and Pardue, 1971) . One to three sections were mounted per slide, deparaflinized in xylene, and rehydrated. The sections were digested with proteinas¢ K, postflxed, treated with triethanolamine/acetic anhydride, washed, and dehydrated.
Probe Preparation
To distinguish between transcripts within the myosin multigerm family, it is necessary to use probes derived from the 3' or 5' noncoding untranslated regions (UTR) of the mRNAs. Appropriate restriction fragments or oligonucleotides were subcloned into the vector, Bluescribe+ (Stratagene Cloning Systems, La Jolla, CA) and grown in E. coli TGI. The following probes were used. (/) 3' UTR of mouse MLC1Atrial mRNA (Barton et al., 1988) GTGGGTC AGAGAAGCCATGTGAGTCCAATACTC CGTAACAGTAAC -AGCCGCTG~TCTCTIC~TTTCTCACGC~GC~CAAGCY. These sequence data are available from EMBL/GenBank/DDJB under accession numbers M20773, M19435, and J03932. (2) 3' UTR of the mouse MLC1-Ventricular mRNA (Lyons et al., 1990b) 
These sequence data are available from EMBL/GenBank/DDJB under accession number X53489. (3) 3' UTR of rat MHCVentricular (MI-IC~) mRNA (Mahdavi et al., 1982) 5'GGTC TC AGCJGC T I C A C A~T I C C ' I W A F J G G~T A G C A C A T -G A T C T A C T C T T C A~C T I " G 3 ' . These sequence data are available from EMBL/GenBank/DDJB under accession number K01463. (4) 3' end of the mouse MHCAtrial (MHC~x) mRNA (Weydert et el., 1985) 5'CGAAC G T T T A T G T T T A T T G~~C A C A G C G A G G G T C T G -CTGGAGAGGTTAT ICCTCGTC3'. These sequence data are available fi'om EMBL/GenBank/DDJB under accession numbe~ M12291 and X5M90. The cRNA transcripts were synthesized according to manufacturer's conditions (Stratagene Cloning Systems) and labeled with 35S-UTP (>1,000 Ci/mmol; Amersham International, Amersham, UK). cRNA transcripts larger than 100 nucleotides were subjected to alkali hydrolysis to give a mean size of 70 bases for efficient hybridization.
Hybridization and Washing Procedures
Sections were hybridized overnight at 52°C in 50% deionized formamide, 0.3 M NaCI, 20 mM Tris-HCl, pH 7.4, 5 mM EDTA, 10 mM NaPO4, 10% dextran sulfate, Ix Denhardt's, 50 /~g/ml total yeast RNA, and 50--75,000 cpm//~l 35S-labeled cRNA probe. The tissue was subjected to stringent washing at 65°C in 50% formamide, 2×SSC, 10 mM DTT and washed in PBS before treatment with 20/~g/ml RNAse A at 37°C for 30 min. Following washes in 2xSSC and 0.1×SSC for 15 min at 37°C, the slides were dehydrated and dipped in Kodak NTB-2 nuclear track emulsion and exposed for 1 wk in light fight boxes with dessicant at 4°C. Photographic development was carried out in Kodak D-19. Slides were analyzed using both light-and dark-field optics of a Zeiss Axiophot microscope. 
Results
By 8 d p.c. in the mouse embryo, a tubular heart has formed and the first myocardial contractions occur (Rugh, 1990; Sissman, 1970) . At first, the tubular heart is S-shaped. Serial sections from the midsagittal section in Fig. 1 c in the order Fig. 1, c, b, d , and e show the lower half of the S-curve, or the atrioventricular junction (Pexeider et al., 1989) , of the developing heart. At this stage, each of the four myosin transcripts that we studied is expressed at a high level in all of the myocardial cells (Fig. 1) . This observation suggests that all of the myosin genes in the heart are upregulated initially in a coordinated fashion. These results are consistent with antibody studies of the myofibrillar proteins in the developing rodent heart, which have shown that, at embryonic day 10-11 in the rat, there is co, expression of MHCot and MHC/3 throughout the heart (De Groot et al., 1989) . Embryonic day 10 in the rat corresponds to 8 d p.c. in the mouse (Rugh, 1990) . Three of the four cardiac myosin transcripts we studied, MHC/5, MLCIA, and MLC1V, are coexpressed in developing skeletal muscle. However, these transcripts are detected in cardiac muscle well before they are detected in developing somites (Fig. 1, b, d , and e; Lyons et al., 1990b) .
The first major change detected in the pattern of myosin transcript distribution in the developing heart occurs around 9 d p.c. At this stage, a distinct atrium and ventricle have formed (Rugh, 1990; Theiler, 1989) . In Fig. 2 , parallel parasagittal sections of a 9.5-d p.c. embryo with 21-24 somites demonstrate that MLC1V mRNAs (Fig. 2 b) are detected in all myocardial cells, whereas MHC/~ (Fig. 2 c) is largely restricted to cells in the ventricle and the outflow tract or ventriculoarterial portion (Pexeider et al., 1989) . Only a few atrial cells continue to express MHC~/ (Fig. 2 c) . MHCot transcripts (Fig. 2 d) are present at high levels in both the atrium and ventricle, but are decreasing in the ventriculoarterial portion. MLCIA mRNAs are expressed in all myocardial cells at this stage (data not shown).
At 9 d p.c., trabeculations are first seen in the ventricles (Sissman, 1970) , and they are clearly visible in ventricles of a 10-d p.c. mouse embryo with 28 somites (Fig. 3) . In the The Journal of Cell Biology, Volume 11 I, 1990 developing heart, the growth rate of the trabeculated regions is thought to be greater than the nontrabeculated portions of heart, because in the adult, the portion of the ventricular wall that is trabeculated accounts for >90% of the total ventricular mass (DeHaan and O'Rahilly, 1978) . In the trabeculated ventricle, the levels of MHCot mRNAs decrease gradually beginning at 10 d pc. (Fig. 3 c) .
Between 10 and 12 d p.c., another difference in the spatial pattern of myosin gene expression in the embryonic heart is detected in the developing sinuatrial transition (Fig. 3) . Transcripts for the atrial isoforms: MLC1A (Fig. 3, a, b , and f) and MHCa (Fig. 3 c) , but not MLC1V (Fig. 3 e) , even though it is coexpressed in atrial cells at this stage, are detected in the sinuatrial transition. MHC/3 is detected at a low level in one portion of the sinuatrial transition (Fig. 3 d, right  arrowhead) . This result agrees in part with the observations of De Groot et al. (1989) , who noted that MHCot and MHC/3 proteins are coexpressed in the developing sinus node in rat embryos. In the sinuatrial transition, there is a distinct ring or column of cells (Anderson et al., 1978) that forms the primordium of the sinus node. Fig. 3 fis a parallel section, hybridized with the MLC1A probe, ,o50/~m from the section in Fig. 3 e, showing the continuity of this ring of cells in the sinuatrial transition. As development proceeds, the level of MHCot mRNAs decreases in the ventricle (Fig. 4 , b and c) and MLC1V transcript levels decrease in the atrium (Fig. 4 a) . Fig. 4 contains two parasagittal sections through the atrioventricular junction and ventriculoarterial component of an ll.5-d p.c. mouse embryo. The endocardial cushions, outflow ridges, and a portion of the developing interventricular septmn can be seen clearly in the phase-contrast micrograph (Fig. 4 b) . The boundary for the expression of the atrial-and ventricular-specific transcripts is the atrioventricular transition (Fig.   4, arrowheads) . The atrioventricular conduction system develops both in this transition and in a portion of the interventricular septum (Viragh and Challice, 1982) .
The next major change in the spatial distribution of cardiac myosin transcripts in the developing fetal heart is shown in Fig. 5 . At 15.5 d p.c., MLCIA transcripts (Fig. 5 a) and MHCt~ transcripts (Fig. 5 d) begin to disappear from the ventricle in a gradient of expression that runs from very low levels of expression in the ventricular wall to high levels of expression in the papillary muscles and interventricular septurn. By 16.5 d p.c., MLC1A transcripts (Fig. 5 e) are only detected in the central portion of the ventricle, and MHCot (Fig. 5 h) transcripts have fallen to a very low level in the ventricle. Both MLC1A and MHCot mRNAs continue to be expressed at high levels in the atria (Fig. 5 , a and e and d and h), and both MLC1V mRNAs (Fig. 5, b and f) and MHC/3 mRNAs (Fig. 5, c and g ) are expressed at high levels in the ventricles.
In addition to their expression within the heart itself, MLC1A and MHCot transcripts are expressed outside of the heart along the pulmonary and caval vessels. Fig. 6 a is a phase-contrast micrograph of a 15.5-d p.o. mouse showing the inferior vena cava which runs from the liver to the right atrium. Under dark-field illumination (Fig. 6 b) , MLC1A transcripts can be seen over portions of the inferior vena cava (arrows) near the liver and close to the atrium. At 17.5 d p.o. (Fig. 6 c) , and at birth (Fig. 6 d) , MLC1A transcripts are detected around pulmonary vessels at some distance from the atrium. MHCo~ transcripts (Fig. 6 e) are also expressed around these vessels. These results are consistent with reports of myocardial extensions or sleeves over pulmonary and caval veins in rodents (Kramer and Marks, 1965; Nathan and Gloobe, 1970) . The hybridization of the MHCot and MLCIA probes to the pulmonary and caval vessels is not due to crosshybridization with smooth muscle myosin transcripts since no hybridization was detected to the smooth muscle in other blood vessels, such as the aorta, or in the gut (data not shown). After decreasing to their lowest level in the fetal ventricle (Fig. 5 h) at 16.5 d p.o., MHCo~ transcripts begin to increase rapidly. At birth, MHCot transcripts (Fig. 6 e) are present at higher levels than MHC/3 transcripts (Fig. 6 f) . This switch continues until MHCo~ transcripts (Fig. 7 b) have replaced MHC/~ transcripts (Fig,.,7 a) in the heart 7 d after birth. This result is consistent with the:~gbservation of Lompr~ et al. (1981) , who detected only MHCot protein in 7-d postnatal mouse ventricles. Also at this stage, MLCIA transcripts (Fig. 7 c) are completely restricted to the atrium and only MLC1V transcripts (Fig. 7 d) are detectable in the ventricle. Table I summarizes the results for in situ hybridization with each of the myosin probes used and lists the number of embryos, fetuses, or postnatal hearts examined at each stage. We did not detect any skeletal muscle-specific MHC or MLC at any stage in the developing heart (Lyons et al., 1990b) . We also were unable to detect any MHC embryonic, which has been reported to be expressed in conductive tissue in rodent hearts (Gorza et al., 1988) around the time of birth (data not shown).
Discussion
We have described the temporal and spatial pattern of expression of four cardiac myosin genes in embryonic and fetal mouse cardiac muscle. Although three of the four myosin gene transcripts we studied are also expressed in skeletal muscle, these genes, encoding MHC/~, MLC1A, and MLCIV, are regulated differently in the two types of striated muscle (see Lyons et al., 1990b) . With the exception of some head muscles, which coexpress developmental isoforms at all stages (Weiczoreck et al., 1985; Soussi-Yanicostas et al., 1990) , myosin gene transcripts and proteins are expressed in a distinct sequence (Whalen et al., 1981; Lyons et al., 1983; Lyons et al., 1990a, b) during skeletal muscle development rather than being upregulated together initially and subsequently modulated during development.
Our results suggest that, in cardiac muscle, myosin genes are all expressed at high levels as soon as the cardiac tube forms, and that the expression of each gene is modulated in a different cell-specific manner during development. At 8 d p.c., in the tubular heart, before distinct atrial and ventricular chambers form, each of the myosin gene transcripts we studied are detected throughout the myocardium. This is consistent with the observation that the first myocardial contractions occur at 8 d p.c. in the mouse (Rugh, 1990; Sissman, 1970) , suggesting that all of the myosin genes are expressed coordinately. In a similar fashion, cardiac and skeletal o~-actin genes are probably coactivated early in cardiac development , although skeletal c~-actin mRNAs are always detected at a low level in the heart. The recent results of Rudnicki et al. (1990) concerning the differentiation of cardiac myocytes from DMSO-treated embryonal carcinoma cells in vitro support our findings. These authors found that MHCt~, MHC/3, MLC2A, and MLC1V proteins were coexpressed in mononucleated myocytes, and they suggest that these cells are analogous to cells of the early embryonic myocardium.
Results of antibody studies of MHCs in the embryonic chick heart (Zhang et al., 1986; Sweeney et al., 1987) have shown that the ventricular MHC protein is expressed *1 d before the atrial MHC protein is detected. We were not able to detect any differences in timing or localization of expression of the contractile protein genes we studied in the embryonic tubular heart of the mouse. In a mouse embryo without somites, at a stage slightly earlier than that shown in Fig.  1 , we observed the same pattern of coexpression of the myosin isoforms (data not shown).
As the cardiac tube loops and rotates upon itself to form the distinct atrial and ventricular chambers, MHC/~ transcript levels decrease rapidly in the atrium, but continue to be expressed at high levels in the ventricle. MHC~ has a lower myosin ATPase than MHCc~ (Hoh et al., 1978) , and cardiac muscle cells expressing MHC/~ have a lower velocity of shortening . These observations suggest that the higher levels of expression of MHC/~ transcripts in the ventricle than in the atrium may correspond to the differences in hemodynamic load in the different chambers of the embryonic heart. This hypothesis is supported by the observation that, after birth, cardiac hypertrophy due to hemodynamic overload is accompanied by a reexpression of MHC/~ transcripts in the rodent ventricle and a decrease in MHCa transcripts (e.g., Izumo et al., 1987) . The changes in the pattern of expression of the MHC genes in the embryonic atria and ventricles may also be correlated with changes in the expression of other genes such as those encoding membrane proteins or cytoplasmic enzymes associated with contraction (Ingwall et al., 1985) .
In the embryonic chick heart, MHC protein isoform expression is correlated with local differences in the contraction pattern of the heart (de Jong et al., 1987) . There is coexpression of MHCot and MHC/$ in parts of the heart with peristaltic contractions, but a single isoform of MHC protein is expressed in synchronously contracting parts of the heart (de Jong et al., 1987) . The switch from peristaltic contraction to synchronous contraction in the chick ventricle coincides with the appearance of trabeculations in the ventricular myocardium and with a switch from coexpression of MHC proteins towards expression of MHC/~ alone (de Jong et al., 1987) .
The pattern of MLC gene expression in the developing mouse heart is not coordinated with that of the MHC genes. MHC# mRNAs are restricted to ventricular cells, except for some cells of the sinuatrial transition, by 10.5 d p.c., but MLC1V mRNAs are detected in atrial cells at a high level until 11.5 d p.c., and at a low level until 15.5 d p.c. This result does not agree with that of Rovner et al. (1990) , who noted that MLC1A is the exclusive MLC1 mRNA expressed in the rat atrium throughout development. MLC1A transcripts continue to be expressed at a high level in ventricular cells as the level of MHC, transcripts drops off gradually in the embryonic mouse ventricle. When MHCt~ transcript levels increase in ventricular cells after 16.5 d p.c., MLC1A transcript levels do not increase, but continue to be restricted to the atrium. Since MLC1A transcripts are expressed in ventricles at stages where MHC/3 is the predominant MHC isoform, and MLC1V is expressed in atria at stages where MHCct is the only MHC isoform, these MLCs must be able to freely associate with either MHC isoform. Whether this association of atrial and ventricular myosin isoforms plays a role in regulating contractility in the heart during development is not clear. There are conflicting reports on the effect of different MLC combinations with MHC on alterations in myosin ATPase and shortening velocity, which are known to be correlated (Barany, 1967) . Wagner and Stone (1983) found that myosin alkali light chain exchange did not increase the ATPase activity of MHC S1 fragments in vitro. However, Sweeney et al. (1988) reported differences in shorterring velocities correlated with myosin alkali light chain ratios in isolated skeletal muscle fibers.
The spatial pattern of decrease in the levels of MLC1A transcripts in fetal ventricles is striking. Beginning at •15 d p.c., MLC1A transcripts begin to disappear in a gradient running from the epicardium toward the endocardium. A similar gradient of expression has been observed for the disappearance of MHC/~ protein in the postnatal developing rat heart (Deschene et al., 1987) . These authors also found that MHC/3 protein reappears later in the rat heart in a gradient of expression in the opposite direction to that in which it disappeared, i.e., the endocardium toward the epicardium. Reexpression of MHC~ protein does not occur in the mature mouse ventricle (Lompr6 et al., 1981) . Hemodynamic factors are known to influence MHC and MLC expression in the adult heart (Swynghedauw, 1986) , and have been implicated in the morphogenesis of the chick heart (Clark, 1984) . It remains to be established whether developmental changes in the distribution of MHC and MLC isoforms are regulated by such factors as intracardial flow patterns, pressure gradients in various chambers, and transmural gradients of wall stress.
It has been clearly demonstrated that some myosin genes are regulated differently in response to cardiac hypertrophy due to hemodynamic overload. In adult rat hearts, which normally have very low levels of MHC/~ transcripts, MHC/~ mRNAs accumulate in the ventricles within 2 d of the onset of cardiac hypertrophy induced by pressure overload (Izumo et al., 1987; Schiaftino et al., 1989) . As MHC/3 expression increases with hypertrophy, MHCot expression decreases. The response to cardiac hypertrophy can vary between species. For example, MLC1V was shown to be induced in overloaded atria in human subjects (Cummins, 1982; Kurabayashi et al., 1988) , but not in rats (McNally et al., 1989) . Some myosin genes, such as MLC1A, appear to be less responsive to cardiac hypertrophy (Rovner et al., 1990) . The mechanisms by which myosin genes are regulated in response to hypertrophy are not known.
The pattern of expression of the MHCa gene in the developing mouse heart is unique in that, after being gradually restricted to atrial cells in the embryo, MHCa transcripts are reexpressed in ventricular cells from 2 d before birth, and replace MHC/3 transcripts by 7 d after birth. Lompr¢ et al. (1984) have suggested that there may be two distinct, developmentally regulated MHCa gene transcripts that differ only at their 3' ends. Our results do not support, but do not rule out, this hypothesis since our MHCa probe is complementary to the 3' UTR of the MHCa gene transcript.
The reexpression of MHCot transcripts may be due to se-rum thyroid hormone levels in the late fetal mouse, because thyroid hormone (T3) has been shown to upregulate MHCot expression and to downregulate MHCB (Lompr~ et al., 1984 Our results support the hypothesis that the mechanisms of myosin gene regulation in these two types of striated muscle must be quite different, since the developmental patterns of expression of myosin genes in skeletal muscle are unlike those detected in cardiac muscle. After an initial high level of coexpression in the myocardium of the embryonic cardiac tube, the expression of each myosin gene is modulated in a different cell-specific and stage-specific manner in developing atrial and ventricular myocytes.
